General Info

WHAT IS THE ACCESS STUDY?

The Assessing outcomes of enhanced Chronic disease Care through patient Education and a value-baSed formulary Study (ACCESS) is a three year study being conducted by investigators at the University of Calgary. The ACCESS study is looking at whether providing preventive medications free of charge for selected high value medications, and a comprehensive patient education program, combined with relay of information on optimal medication use from patients to their healthcare providers, will improve people’s health.

WHAT IS THE PURPOSE OF THE STUDY?

The purpose of this study is to look at ways to improve health for Alberta seniors (age 65 or older) with chronic health conditions including heart disease, stroke, kidney disease, or a combination of diabetes, high blood pressure, and other risk factors for heart disease (high cholesterol and smoking).

WHAT ARE WE INVESTIGATING?

In this three year study, we are testing the impact of two interventions:

1) Preventive medications free of charge: receiving preventive medications for diabetes, high blood pressure, or heart disease without co-payment through Alberta Blue Cross Coverage for Seniors Program and

2) Personalized education program to help seniors manage their chronic conditions: receiving a comprehensive patient education program tailored to individual needs.

HOW TO CONTACT US

Contact Information
Study coordinator:
Email: accesstrial@ucalgary.ca
(Toll free) Phone number: 1-844-310-0585

Lead
Dr. Braden Manns

ETHICS APPROVAL

The study has been approved by the Research Ethics Board at the University of Calgary and is funded by Alberta Innovates Health Solutions.

This website represents best clinical evidence arrived at after careful consideration and does not override the individual responsibility of healthcare professionals to make decisions appropriate to the patient, in consultation with the patient and/or guardian or caregiver. Implementation of this information is the responsibility of the healthcare professional with due regard to the condition of the individual patient. Nothing in this information should be interpreted in a way that would be consistent with those responsibilities.